We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA said yesterday that it has reviewed more than 230 clinical trials of potential COVID-19 treatments so far through its Coronavirus Treatment Acceleration Program (CTAP). Read More
Senate Democrats are calling on Congress for $25 billion in emergency funding to support the production and distribution of a COVID-19 vaccine — and for the Trump administration to lay out a distribution plan for a COVID-19 vaccine or vaccines no later than Aug. 7. Read More
Moderna’s potential COVID-19 vaccine generated neutralizing antibodies in patients, according to a phase 1 trial run by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Read More
Shanghai-based Junshi Biosciences announced that it has finished enrolling participants in a phase 1 trial of JS016, its COVID-19 neutralizing antibody. Read More
The test is only authorized for the duration of the COVID-19 pandemic and the labeling must state that the test “has not been FDA approved or cleared,” the agency said. Read More